Ginkgo Bioworks
DNA
167 hedge funds and large institutions have $184M invested in Ginkgo Bioworks in 2025 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 49 increasing their positions, 31 reducing their positions, and 28 closing their positions.
59% more call options, than puts
Call options by funds: $5.98M | Put options by funds: $3.75M
58% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 31
14% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 28
1% more funds holding
Funds holding: 166 → 167 (+1)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.14% less ownership
Funds ownership: 71.91% → 71.77% (-0.14%)
42% less capital invested
Capital invested by funds: $319M → $184M (-$135M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Erste Asset Management
Vienna,
Austria
|
+$9.28M |
| 2 |
Millennium Management
New York
|
+$7.72M |
| 3 |
BSWM
Boston Standard Wealth Management
Winchester,
Massachusetts
|
+$6.18M |
| 4 |
Legal & General Group
London,
United Kingdom
|
+$5.78M |
| 5 |
JMFC
J.M. Forbes & Co
Boston,
Massachusetts
|
+$4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$28.1M |
| 2 |
D.E. Shaw & Co
New York
|
-$5.37M |
| 3 |
Two Sigma Investments
New York
|
-$3.37M |
| 4 |
Two Sigma Advisers
New York
|
-$2.89M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$2.86M |
DNA Hedge Fund Activity: Q1 2025 in Review
167 of the 7,471 institutional investors tracked by Wall St. Rank reported a position in Ginkgo Bioworks (DNA) for Q1 2025, worth a combined $184M — down 42% from $319M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new DNA positions and 28 closed out — a net gain of 4 holders — while 49 added to existing stakes and 31 trimmed.
The largest buyer was Erste Asset Management, adding an estimated $9.28M. The largest seller was Bank of America, cutting an estimated $28.1M.
- 167 institutional investors held Ginkgo Bioworks (DNA) as of Q1 2025, up from 166 in Q4 2024.
- Funds reported $184M of Ginkgo Bioworks stock for Q1 2025, down 42% quarter-over-quarter.
- 32 funds opened new Ginkgo Bioworks positions in Q1 2025 and 28 closed out, a net change of +4 holders.
- The largest Ginkgo Bioworks buyer in Q1 2025 was Erste Asset Management, an estimated $9.28M added.
- The largest Ginkgo Bioworks seller in Q1 2025 was Bank of America, an estimated $28.1M sold.
Based on aggregated 13F filings for Q1 2025.